Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 93

Sort by

Sort Order Select

Journal Articles

RT-PCR-Based MRD Detection in NPM1 Mutated AML: A Prospective Follow-Up Study in 130 Patients.

Susanne Schnittger, PhD, Wolfgang Kern, MD, Claudia Schoch, MD, Torsten Haferlach, MD

Blood (2007) 110 (11): 545.

https://doi.org/10.1182/blood.V110.11.545.545

Published: 2007

Journal Articles

Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL)

Blood (2006) 109 (8): 3451–3461.

https://doi.org/10.1182/blood-2006-08-041012

Published: 2006

Includes: Supplemental data

Journal Articles

Trisomy 13 Defines a Subgroup of Myeloid Malignancies with an Extremely High Frequency of AML1 Gene Mutations and Newly Defined VEGFR-1 Mutations.

Frank Dicker, PhD, Claudia Schoch, MD, Torsten Haferlach, MD, Wolfgang Kern, MD, Susanne Schnittger, PhD

Blood (2006) 108 (11): 562.

https://doi.org/10.1182/blood.V108.11.562.562

Published: 2006

Journal Articles

Application of Multiparameter Flow Cytometry for the Identification of Dysplasia in Granulocytic, Monocytic, and Erythrocytic Lineages and Blasts in Patients with Myelodysplastic Syndromes.

Wolfgang Kern, MD, Claudia Schoch, M.D., Susanne Schnittger, Ph.D., Torsten Haferlach, M.D.

Blood (2006) 108 (11): 2615.

https://doi.org/10.1182/blood.V108.11.2615.2615

Published: 2006

Journal Articles

Chromosome Banding Analysis Allows a More Precise Classification of CLL Than Interphase FISH: A Study on 446 Cases.

Claudia Schoch, MD, Frank Dicker, PhD, Susanne Schnittger, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD

Blood (2006) 108 (11): 297.

https://doi.org/10.1182/blood.V108.11.297.297

Published: 2006

Journal Articles

5q Deletions Can Be Identified Based on the Expression Level of 5q Genes: A Study on 49 Cases with MDS or AML Analysed in Parallel by Gene Expression Profiling and Genomic Arrays.

Claudia Schoch, MD, Sonja Rauhut, Susanne Schnittger, PhD, Frank Dicker, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD

Blood (2006) 108 (11): 2642.

https://doi.org/10.1182/blood.V108.11.2642.2642

Published: 2006

Journal Articles

Changes in the Hierarchy of Risk Factors with Older Age in De-Novo Acute Myeloid Leukemia (AML).

Thomas Buchner, MD, Wolfgang E. Berdel, MD, Claudia Schoch, MD, Torsten Haferlach, MD, Hubert L. Serve, MD, Joachim Kienast, MD, Susanne Schnittger, PhD, Wolfgang Kern, MD, Joelle Tchinda, MD, Albrecht Reichle, MD, Peter Staib, MD, Wolf-Dieter Ludwig, MD, Carlo Aul, MD, Maria Cristina Sauerland, Dipl Math, Achim Heinecke, PhD, Bernhard Josef Wormann, MD, Wolfgang Hiddemann, MD

Blood (2006) 108 (11): 1977.

https://doi.org/10.1182/blood.V108.11.1977.1977

Published: 2006

Journal Articles

Intensification of Induction by High-Dose AraC and Outcome in Older Patients with De-Novo Acute Myeloid Leukemia (AML) and Subsets.

Thomas Buchner, MD, Wolfgang E. Berdel, MD, Claudia Schoch, MD, Torsten Haferlach, MD, Joelle Tchinda, MD, Susanne Schnittger, PhD, Wolfgang Kern, MD, Albrecht Reichle, MD, Peter Staib, MD, Hubert L. Serve, MD, Wolf-Dieter Ludwig, MD, Maria Cristina Sauerland, Dipl Math, Achim Heinecke, PhD, Bernhard Josef Wormann, MD, Wolfgang Hiddemann, MD

Blood (2006) 108 (11): 1978.

https://doi.org/10.1182/blood.V108.11.1978.1978

Published: 2006

Journal Articles

Mutations of the TP53 Gene Occur in 13.4% of Acute Myeloid Leukemia and Are Strongly Associated with a Complex Aberrant Karyotype.

Claudia Schoch, MD, Frank Dicker, PhD, Hannes Herholz, Susanne Schnittger, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD

Blood (2006) 108 (11): 1913.

https://doi.org/10.1182/blood.V108.11.1913.1913

Published: 2006

Journal Articles

The Incidence of TP53 Mutations Is Low in Leukemia Overall but High in the Subgroups with Complex Aberrant Karyotypes: A Study on 309 Cases.

Frank Dicker, PhD, Hannes Herholz, Wolfgang Kern, MD, Torsten Haferlach, MD, Susanne Schnittger, PhD, Claudia Schoch, MD

Blood (2006) 108 (11): 4340.

https://doi.org/10.1182/blood.V108.11.4340.4340

Published: 2006

Journal Articles

High Frequency of P53 Mutations Detected by a Microarray Resequencing Assay, the AmpliChip P53 Test, in AML with a Complex Aberrant Karyotype.

Nancy Patten, Sim Truong, Jeff Fu, Frank Dicker, Ph.D., Susanne Schnittger, Ph.D., Wolfgang Kern, MD, Alexander Kohlmann, Ph.D., Torsten Haferlach, MD, Claudia Schoch, MD, Lin Wu, Ph.D.

Blood (2006) 108 (11): 4341.

https://doi.org/10.1182/blood.V108.11.4341.4341

Published: 2006

Journal Articles

Correlation of Flow Cytometrically Determined Expression of ZAP-70 Using Two Different Antibodies with IgVH Mutation Status and Cytogenetics in 539 Patients with Chronic Lymphocytic Leukemia.

Wolfgang Kern, MD, Frank Dicker, Ph.D., Susanne Schnittger, Ph.D., Claudia Schoch, M.D., Torsten Haferlach, M.D.

Blood (2006) 108 (11): 495.

https://doi.org/10.1182/blood.V108.11.495.495

Published: 2006

Journal Articles

The Number of Cooperating Mutations in AML Is Still Growing: A Study on 3789 Patients.

Susanne Schnittger, PhD, Claudia Schoch, MD, Ulrike Bacher, MD, Frank Dicker, MD, Wolfgang Kern, MD, Torsten Haferlach, MD

Blood (2006) 108 (11): 801.

https://doi.org/10.1182/blood.V108.11.801.801

Published: 2006

Journal Articles

3′ Position of the FLT3-LM and Loss of Heterozygosity Are Highly Correlated to Unfavourable Outcome in AML.

Susanne Schnittger, PhD, Claudia Schoch, MD, Wolfgang Kern, MD, Torsten Haferlach, MD

Blood (2006) 108 (11): 807.

https://doi.org/10.1182/blood.V108.11.807.807

Published: 2006

Journal Articles

Characterization of Two New Imatinib-Responsive Fusion Genes Generated by Disruption of PDGFRB in Eosinophilia-Associated Chronic Myeloproliferative Disorders.

Christoph Walz, MD, Georgia Metzgeroth, MD, Claudia Schoch, MD, Torsten Haferlach, MD, Rudiger Hehlmann, MD, Andreas Hochhaus, MD, Nicholas C.P. Cross, PhD, Andreas Reiter, MD

Blood (2006) 108 (11): 667.

https://doi.org/10.1182/blood.V108.11.667.667

Published: 2006

Journal Articles

Ubiquitously Expressed Micro RNA miR-16 Is Not Mutated and Not Differentially Expressed in Patients with B-CLL.

Pablo Landgraf, MD, Uta Fuchs, PhD, Astrid Novosel, MD, Valerio Fulci, PhD, Claudia Schoch, MD, Torsten Haferlach, MD, Raymund Buhmann, MD, Thomas Tuschl, PhD, Arndt Borkhardt

Blood (2006) 108 (11): 496.

https://doi.org/10.1182/blood.V108.11.496.496

Published: 2006

Journal Articles

Immunostimulatory oligonucleotide-induced metaphase cytogenetics detect chromosomal aberrations in 80% of CLL patients: a study of 132 CLL cases with correlation to FISH, IgV H status, and CD38 expression

Frank Dicker, Susanne Schnittger, Torsten Haferlach, Wolfgang Kern, Claudia Schoch

Blood (2006) 108 (9): 3152–3160.

https://doi.org/10.1182/blood-2006-02-005322

Published: 2006

Includes: Supplemental data

Journal Articles

PCR-Based MRD Detection in AML with Normal Karyotype or Other intermediate Risk Aberrations by the Use of FLT3-LM, NPM1-Mutations, MLL-PTD or WT1-Overexpression.

Susanne Schnittger, PhD, Claudia Schoch, MD, Wolfgang Kern, MD, Torsten Haferlach, MD

Blood (2006) 108 (11): 2297.

https://doi.org/10.1182/blood.V108.11.2297.2297

Published: 2006

Journal Articles

Centrosome Aberrations, Disturbed Mitotic Spindle Formation and G1 Arrest in Normal and Leukemic Cells Treated with the SRC/ABL Inhibitor Dasatinib.

Alice Fabarius, PhD, Michelle Giehl, Alwin Kraemer, MD, Oliver Frank, PhD, Martin C. Mueller, MD, Peter Duesberg, PhD, Tanja Lahaye, MD, Claudia Schoch, MD, Rudiger Hehlmann, MD, Wolfgang Seifarth, PhD, Andreas Hochhaus, MD

Blood (2006) 108 (11): 2167.

https://doi.org/10.1182/blood.V108.11.2167.2167

Published: 2006

Journal Articles

Prospective Multicenter Study for Patients with Therapy - Related Acute Myeloid Leukemia (AML) Using Intensive Induction and Postremission Therapy.

Bernhard Josef Wormann, MD, Claudia Schoch, MD, Albrecht Reichle, MD, Peter Staib, MD, Wolf-Dieter Ludwig, MD, Maria Cristina Sauerland, Achim Heinecke, PhD, Wolfgang E. Berdel, MD, Wolfgang Hiddemann, MD, Thomas Buchner, MD

Blood (2006) 108 (11): 2001.

https://doi.org/10.1182/blood.V108.11.2001.2001

Published: 2006

NARROW

RT-PCR-Based MRD Detection in NPM1 Mutated AML: A Prospective Follow-Up Study in 130 Patients.

Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL)

Trisomy 13 Defines a Subgroup of Myeloid Malignancies with an Extremely High Frequency of AML1 Gene Mutations and Newly Defined VEGFR-1 Mutations.

Application of Multiparameter Flow Cytometry for the Identification of Dysplasia in Granulocytic, Monocytic, and Erythrocytic Lineages and Blasts in Patients with Myelodysplastic Syndromes.

Chromosome Banding Analysis Allows a More Precise Classification of CLL Than Interphase FISH: A Study on 446 Cases.

5q Deletions Can Be Identified Based on the Expression Level of 5q Genes: A Study on 49 Cases with MDS or AML Analysed in Parallel by Gene Expression Profiling and Genomic Arrays.

Changes in the Hierarchy of Risk Factors with Older Age in De-Novo Acute Myeloid Leukemia (AML).

Intensification of Induction by High-Dose AraC and Outcome in Older Patients with De-Novo Acute Myeloid Leukemia (AML) and Subsets.

Mutations of the TP53 Gene Occur in 13.4% of Acute Myeloid Leukemia and Are Strongly Associated with a Complex Aberrant Karyotype.

The Incidence of TP53 Mutations Is Low in Leukemia Overall but High in the Subgroups with Complex Aberrant Karyotypes: A Study on 309 Cases.

High Frequency of P53 Mutations Detected by a Microarray Resequencing Assay, the AmpliChip P53 Test, in AML with a Complex Aberrant Karyotype.

Correlation of Flow Cytometrically Determined Expression of ZAP-70 Using Two Different Antibodies with IgVH Mutation Status and Cytogenetics in 539 Patients with Chronic Lymphocytic Leukemia.

The Number of Cooperating Mutations in AML Is Still Growing: A Study on 3789 Patients.

3′ Position of the FLT3-LM and Loss of Heterozygosity Are Highly Correlated to Unfavourable Outcome in AML.

Characterization of Two New Imatinib-Responsive Fusion Genes Generated by Disruption of PDGFRB in Eosinophilia-Associated Chronic Myeloproliferative Disorders.

Ubiquitously Expressed Micro RNA miR-16 Is Not Mutated and Not Differentially Expressed in Patients with B-CLL.

Immunostimulatory oligonucleotide-induced metaphase cytogenetics detect chromosomal aberrations in 80% of CLL patients: a study of 132 CLL cases with correlation to FISH, IgV H status, and CD38 expression

PCR-Based MRD Detection in AML with Normal Karyotype or Other intermediate Risk Aberrations by the Use of FLT3-LM, NPM1-Mutations, MLL-PTD or WT1-Overexpression.

Centrosome Aberrations, Disturbed Mitotic Spindle Formation and G1 Arrest in Normal and Leukemic Cells Treated with the SRC/ABL Inhibitor Dasatinib.

Prospective Multicenter Study for Patients with Therapy - Related Acute Myeloid Leukemia (AML) Using Intensive Induction and Postremission Therapy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only